Pediatric Pulmonary Vascular Disease

Long-term outcomes of transcatheter Potts shunt in children with suprasystemic pulmonary arterial hypertension

Raymond N. Haddad, Maryline Levy, Isabelle Szezepanski, Sophie Malekzadeh-Milani, Damien BonnetHôpital Universitaire Necker-Enfants Malades and Université de Paris Cité.France Frontiers in Cardiovascular MedicineFront Cardiovasc Med 2022; 9: DOI: 10.3389/fcvm.2022.1028304 AbstractBackground: Transcatheter Potts shunt (TPS) is a palliation alternative for children with severe pulmonary arterial hypertension (PAH). Debates on the long-term outcomes remain unsolved.Objectives: To evaluate long-term clinical and […]

Long-term outcomes of transcatheter Potts shunt in children with suprasystemic pulmonary arterial hypertension Read More »

Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension

Hannes Sallmon, Martin Koestenberger, Alexander Avian, Friedrich Reiterer, Bernhard Schwaberger, Katharina Meinel, Gerhard Cvirn, Stefan Kurath-Koller, Andreas Gamillscheg, Georg HansmannEuropean Pediatric Pulmonary Vascular Disease Network. Charité-Universitätsmedizin Berlin. Deutsches Herzzentrum Berlin. Medical University Graz. Hannover Medical School. Germany and Austria Journal of PerinatologyJ Perinatol 2022; 42: 781-787DOI: 10.1038/s41372-022-01374-w AbstractObjective: Extremely low gestational age newborns (ELGANs) represent an especially

Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension Read More »

Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH

Georg Hansmann, Franziska Diekmann, Philippe Chouvarine, Fabio Ius, Julia Carlens, Nicolaus Schwerk, Gregor Warnecke, Jens Vogel-Claussen, Dagmar Hohmann, Tim Alten, Thomas JackEuropean Pediatric Pulmonary Vascular Disease Network. Hannover Medical School. University Hospital Heidelberg.Germany Journal of Heart and Lung TransplantationJ Heart Lung Transplant 2022; 41: 187-198DOI: 10.1016/j.healun.2021.10.014 AbstractBackground: We investigated whether RV function recovers in children with pulmonary

Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH Read More »

Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension

Mayank Sharma, Michael A. Bellio, Merline Benny, Shathiyah Kulandavelu, Pingping Chen, Chawisa Janjindamai, Chenxu Han, Liming Chang, Shanique Sterling, Kevin Williams, Andreas Damianos, Sunil Batlahally, Kaitlyn Kelly, Daniela Aguilar-Caballero, Ronald Zambrano, Shaoyi Chen, Jian Huang, Shu Wu, Joshua M. Hare, Augusto Schmidt, Aisha Khan, Karen YoungUniversity of Miami Miller School of Medicine.United States Stem Cells Translational Medicine Stem Cells Transl Med 2022; 11: 828-840DOI: 10.1093/stcltm/szac041 AbstractMesenchymal stem cell (MSC) extracellular vesicles (EVs) have beneficial effects in preclinical bronchopulmonary

Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension Read More »

Effects of Inhaled Iloprost for the Management of Persistent Pulmonary Hypertension of the Newborn

Sourabh Verma, Rishi Lumba, Sadaf H. Kazmi, Michelle J. Vaz, Shrawani Soorneela Prakash, Sean M. Bailey, Pradeep V. Mally, Tara M. RandisNYU Grossman School of Medicine. University of South Florida. United States American Journal of PerinatologyAm J Perinatol 2022; 39: 1441-1448DOI: 10.1055/s-0040-1722653 AbstractObjective: The study aimed to evaluate the effects of inhaled iloprost on oxygenation indices in

Effects of Inhaled Iloprost for the Management of Persistent Pulmonary Hypertension of the Newborn Read More »

Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial

Safaa S. Iman, Rania A. El-Farrash, Amr S. Taha, Ghada A. SalehAin Shams University and Cairo Ministry of Health.Egypt Journal of Cardiovascular PharmacologyJ Cardiovasc Pharmacol 2022; 80: 746-752DOI: 10.1097/FJC.0000000000001332 AbstractPersistent pulmonary hypertension of the newborn (PPHN) is a condition caused by failure of pulmonary vascular adaptation at birth, resulting in severe hypoxia. Several therapeutic modalities are

Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial Read More »

A case of acquired von Willebrand disease in severe pediatric pulmonary hypertension contributing to bleeding following reverse Potts shunt

Rachel T. Sullivan, Clara Lo, Elisabeth Martin, Rebecca J. Kameny, Rachel K. HopperStanford University School of Medicine and Lucile Packard Children’s Hospital.United States Pulmonary CirculationPulm Circ 2022; 12: DOI: 10.1002/pul2.12042 AbstractThe reverse Potts shunt is increasingly used as a palliative measure for end-stage pulmonary arterial hypertension (PAH) as a means to offload the right ventricle and

A case of acquired von Willebrand disease in severe pediatric pulmonary hypertension contributing to bleeding following reverse Potts shunt Read More »

Factors associated with discontinuation of pulmonary vasodilator therapy in children with bronchopulmonary dysplasia-associated pulmonary hypertension

Catherine M. Avitabile, Xuemei Zhang, Steve B. Ampah, Yan Wang, Devon Ash, Kathleen Nilan, Laura Mercer-Rosa, Julie L. Fierro, David B. Frank, Kathleen A. GibbsUniversity of Pennsylvania and Children’s Hospital of Philadelphia.United States Journal of PerinatologyJ Perinatol 2022; 42: 1246-1254DOI: 10.1038/s41372-022-01421-6 AbstractObjective: To evaluate factors associated with discontinuation of pulmonary vasodilator therapy in bronchopulmonary dysplasia-related pulmonary hypertension

Factors associated with discontinuation of pulmonary vasodilator therapy in children with bronchopulmonary dysplasia-associated pulmonary hypertension Read More »

Late onset of pulmonary hypertension in very low birth weight infants

Joseph Ginski, Dmitry Tumin, Devon Kuehn, Jason Higginson, Scott MacGilvrayEast Carolina UniversityUnited States Journal of Maternal Fetal and Neonatal MedicineJ Matern Fetal Neonatal Med 2022; 35: 3516-3518DOI: 10.1080/14767058.2020.1826924 AbstractIntroduction: Pulmonary hypertension (PH) is a recognized complication of bronchopulmonary dysplasia (BPD). Recent guidelines recommend evaluating all infants with BPD for PH via echocardiogram, but the specific timing of this screening

Late onset of pulmonary hypertension in very low birth weight infants Read More »

Predicting treatment of pulmonary hypertension at discharge in infants with congenital diaphragmatic hernia

Burhan Mahmood, Karna Murthy, Natalie Rintoul, Mark Weems, Sarah Keene, Beverly Brozanski, Robert DiGeronimo, Beth Haberman, Holly Hedrick, Jason Gien, Ruth Seabrook, Noorjahan Ali, Rachel Chapman, John Daniel, Allen Harrison, Yvette Johnson, Nicolas F. M. Porta, Michael Uhing, Isabella Zaniletti, Theresa R. GroverChildren’s Hospitals Neonatal ConsortiumUnited States Journal of PerinatologyJ Perinatol 2022; 42: 45-52DOI: 10.1038/s41372-021-01249-6 AbstractObjective: To

Predicting treatment of pulmonary hypertension at discharge in infants with congenital diaphragmatic hernia Read More »

Scroll to Top